These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 1564023
1. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD. J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023 [Abstract] [Full Text] [Related]
6. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA. Pediatrics; 1995 Aug; 96(2 Pt 1):320-5. PubMed ID: 7630692 [Abstract] [Full Text] [Related]
7. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder. Sebrechts MM, Shaywitz SE, Shaywitz BA, Jatlow P, Anderson GM, Cohen DJ. Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535 [Abstract] [Full Text] [Related]
9. Comparison of sustained-release and standard methylphenidate in the treatment of minimal brain dysfunction. Whitehouse D, Shah U, Palmer FB. J Clin Psychiatry; 1980 Aug; 41(8):282-5. PubMed ID: 7400107 [Abstract] [Full Text] [Related]
12. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE. J Clin Oncol; 2004 Dec 01; 22(23):4795-803. PubMed ID: 15570081 [Abstract] [Full Text] [Related]
13. A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Kotarski M, Spencer T. J Clin Psychopharmacol; 2010 Oct 01; 30(5):549-53. PubMed ID: 20814332 [Abstract] [Full Text] [Related]
14. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data. Sonuga-Barke EJ, Swanson JM, Coghill D, DeCory HH, Hatch SJ. BMC Psychiatry; 2004 Sep 30; 4():28. PubMed ID: 15458569 [Abstract] [Full Text] [Related]
15. Effects of methylphenidate on attention and nonverbal learning in children with attention-deficit hyperactivity disorder. O'Toole K, Abramowitz A, Morris R, Dulcan M. J Am Acad Child Adolesc Psychiatry; 1997 Apr 30; 36(4):531-8. PubMed ID: 9100428 [Abstract] [Full Text] [Related]
16. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H. Psychiatry Clin Neurosci; 2009 Apr 30; 63(2):167-75. PubMed ID: 19335386 [Abstract] [Full Text] [Related]
17. Does methylphenidate normalize the classroom performance of children with attention deficit disorder? DuPaul GJ, Rapport MD. J Am Acad Child Adolesc Psychiatry; 1993 Jan 30; 32(1):190-8. PubMed ID: 8428871 [Abstract] [Full Text] [Related]
19. Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD. Kim Y, Shin MS, Kim JW, Yoo HJ, Cho SC, Kim BN. Hum Psychopharmacol; 2009 Mar 30; 24(2):95-102. PubMed ID: 19226534 [Abstract] [Full Text] [Related]
20. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Coghill DR, Rhodes SM, Matthews K. Biol Psychiatry; 2007 Nov 01; 62(9):954-62. PubMed ID: 17543895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]